GenScript is a global biotechnology group. GenScript’s businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, as well as cell therapy.
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions around the world have used GenScript’s premier, convenient, and reliable products and services.
GenScript currently has more than 3000 employees globally, 33% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis and bioinformatics, including more than 70 patents and over 200 patent applications. As of January 2019, GenScript's products and services have been cited by 36,500 scientific papers worldwide.
GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.
For more information, visit www.genscript.com
Sensitech Inc. is a global leader in delivering supply chain visibility solutions. Our innovative monitoring products and services help to maintain the quality, integrity, and security of our customers’ valuable products at every step in their journey, all around the world.
For 30 years, leading companies in the food, pharmaceutical, industrial, consumer goods, and other industries have relied on Sensitech to help protect their products—and their bottom lines. Sensitech is a Carrier company, a leading provider of heating, air conditioning, and refrigeration systems, building controls and automation, and fire and security systems leading to safer, smarter, sustainable, and high-performance buildings. Sensitech Inc. is headquartered in Beverly, Mass., with over 35 sales,
service, and distribution locations around the world.
For more information please visit www.sensitech.com
For pharma customers worldwide, Aptar Pharma is the go-to drug delivery expert, providing innovative drug delivery systems, components, and active packaging solutions across the widest range of delivery routes including nasal, pulmonary, ophthalmic, dermal, and injectables, providing complete solutions to customers’ delivery challenges.
Aptar Pharma Services provides a wide array of early-stage to commercialization support to accelerate and de-risk the development journey and includes services from industry experts Next Breath, Gateway Analytical, Nanopharm, and Noble.
With a strong focus on innovation, Aptar Pharma is leading the way in developing digital healthcare solutions, including connected devices, to help improve patient outcomes. With a global manufacturing footprint of 14 GMP manufacturing sites, Aptar Pharma provides security-of-supply and local support to customers. Aptar Pharma is part of AptarGroup, Inc. (NYSE:ATR).
Technology Showcase Sponsor
PharmaJet’s mission is to improve people’s lives through needle-free technology. The PharmaJet Needle-free Systems provide increased vaccine effectiveness, a preferred patient and caregiver experience, and a proven path to
commercialization. They are also safe, fast, and easy to use. The Stratis ® System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis ® System has CE Mark and WHO PQS certification for intradermal injections.
For more information visit www.pharmajet.com.
FUJIFILM Wako Pure Chemical Corporation has been providing highly functional and high-quality laboratory chemicals, specialty chemicals, and clinical diagnostic reagents based on advanced technological development, to address various
customer needs as a general reagent manufacturer.
The Fujifilm Group regards two businesses as its growth drivers: the healthcare business, which addresses the three domains of prevention, diagnosis, and treatment; and the highly functional materials business, which handles materials and resources used in a range of industrial fields. FUJIFILM Wako Pure Chemical Corporation has been promoting business activities as the core group company
handling healthcare and highly functional materials businesses of the Fujifilm Group through proactive business expansion overseas, in addition to applying the rigorous R&D, manufacturing, and sales base that has been built up in Japan over many years.
At this exhibition, we are proud to introduce our product line WakoVAC; and its culture media series available to use in vaccine manufacturing.
Please visit http://ffwk.fujifilm.co.jp/en/index.html, https://labchem- wako.fujifilm.com/asia/index.html, or our booth to find out more.
Every Elitech product
Pfanstiehl is the market leader of high purity / low endotoxin-low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all of the leading global biopharmaceutical companies. Pfanstiehl was founded in 1919 and currently celebrating its 102nd anniversary year in 2021. Pfanstiehl is headquartered at Waukegan, IL, USA and has global presence with sales offices in Switzerland for EMEA & in Singapore for APAC.
Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s excipients are critical components in the majority of the top global blockbuster biopharmaceutical drugs & vaccines which have been administered to thousands of patients around the world. Pfanstiehl’s high purity, low endotoxin and low metals Carbohydrates & Amino acids are known as “best in class” due to their high purity, performance, consistency and quality attributes.
For more information, please visit: www.pfanstiehl.com
ABOUT CHIME BIOLOGICS
Chime Biologics, a China-based, world-class Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide one stop comprehensive solution supporting our customers from early-stage biopharmaceutical development through late-stage clinical and commercial manufacturing, catering to the evolving needs of the dynamic biopharmaceutical industry. We pledge to make world- class biopharmaceuticals affordable and accessible to all patients globally through manufacturing innovation, and empowering therapeutic advancement for improvement of human health.
With our State-of-the-art facility and in-house world class expert team, we are committed for excellence upholding highest degree of integrity. We are ISO 14001:2015 and ISO 45001:2018 certified. Our World’s first GE KuBio facility is located at Wuhan’s BioLake biotech industry development zone of China, with clear path to expand the total capacity up to 140,000+ in the near future.
Phone:+86 27 8787 9208
DBT/Wellcome Trust India Alliance (India Alliance) is an independent, dynamic public charity that funds research in health and biomedical sciences in India. India Alliance invests in transformative ideas and supportive research ecosystems to advance discovery and innovation to improve health and well-being. India Alliance stands for diversity, inclusivity, and transparency in science and works to facilitate the engagement of science with society.
India Alliance is funded by the Department of Biotechnology (DBT), the Government of India, and the Wellcome Trust, United Kingdom.
For 10 years, India Alliance has enabled high-quality, internationally competent biomedical research in India. Moving ahead, India Alliance is now set on a path to advance discovery and innovation to improve health in India. Its strategic plan is directed to-
1. Invest in basic biomedical, clinical, and public health research to tackle health challenges
2. Strengthen India’s research ecosystem to drive discovery and innovation
3. Engage with stakeholders to improve health for all
The Department of Biotechnology (DBT), under the Ministry of Science and Technology, Government of India, has been instrumental in the development of the field of modern biology and biotechnology in India. DBT with its intimate involvement with the nation’s effort to build capacity in human resources has greatly strengthened India Alliance’s capacity.